计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
L409285-1ml |
1ml |
现货 ![]() |
|
英文别名 | Benzeneacetamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-α-hydroxy-, (αS)- |
---|---|
规格或纯度 | 10mM in DMSO |
英文名称 | LY411575 |
生化机理 | LY411575 是一种强效的 γ 分泌酶抑制剂,其 IC50 为 0.078 nM/0.082 nM(膜基/细胞基),在表达 APP 或 NΔE 的 HEK293 细胞中也能抑制 Notch 的裂解,其 IC50 为 0.39 nM。LY411575 可诱导细胞凋亡。 |
储存温度 | -80℃储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
LY411575是γ-secretase抑制剂,基于膜和细胞的实验IC50分别为0.078 nM/0.082 nM,还能抑制Notch clevage,IC50为0.39 nM。A potent γ-secretase inhibitor Information LY411575 is a potentγ-secretaseinhibitor withIC50of 0.078 nM/0.082 nM (membrane/cell-based), also inhibits Notch cleavage withIC50of 0.39 nM in APP or NΔE expressing HEK293 cells. LY411575 inducesapoptosis. LY-411575 inhibits γ-secretase which can be assessed by the substrates like amyloid precursor protein (APP) and Notch S3 cleavage. LY-411575, which blocks Notch activation, results in apoptosis in primary and immortalized KS cells. In vivo 10 mg/kg oral dose of LY-411575 decreases brain and plasma Aβ40 and -42 dose-dependently. LY-411575 reduces cortical Aβ40 in young (preplaque) transgenic CRND8 mice (ED50 ≈ 0.6 mg/kg) and produces significant thymus atrophy and intestinal goblet cell hyperplasia at higher doses (>3 mg/kg). The therapeutic window is similar after oral and subcutaneous administration and in young and aged CRND8 mice. Both the thymus and intestinal side effects are reversible after a 2-week washout period. Three-week treatment with 1 mg/kg LY411575 reduces cortical Aβ40 by 69% without inducing intestinal effects, although a previously unreported change in coat color is observed. cell lines: Concentrations:500 μM Incubation Time:24 hours Powder Purity:≥99% |
IC50 | Notch S3 cleavage, IC50: 0.39 nM |
---|---|
ALogP | 2.625 |
hba_count | 3 |
HBD Count | 3 |
Rotatable Bond | 5 |
分子类型 | 小分子 |
---|---|
Canonical SMILES | CC(NC(=O)C(O)C1=CC(=CC(=C1)F)F)C(=O)NC2C(=O)N(C)C3=C(C=CC=C3)C4=C2C=CC=C4 |
分子量 | 479.48 |
Reaxy-Rn | 54940486 |
Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=54940486&ln= |
溶解性 | Solubility (25°C) In vitro DMSO: 10 mg/mL warmed with 50ºC Water: bath (74.0 mM); 5%TFA 6.03 mg/mL (44.62 mM); Water: Insoluble; |
---|---|
DMSO(mg / mL) Max Solubility | 95 |
DMSO(mM) Max Solubility | 198.13 |
Water(mg / mL) Max Solubility | <1 |
Reaxy-Rn | 54940486 |
---|---|
Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=54940486&ln= |
Concentration | 9-11(mmol/L) |
---|---|
Proton NMR spectrum | Conforms to Structure |